Do I Need a Pacemaker or ICD for Myotonic Dystrophy?
At a Glance
People with myotonic dystrophy type 1 (DM1) are at high risk for heart conduction issues that cause the heart to beat dangerously slow or fast. Regular monitoring with ECGs helps doctors catch electrical delays early, allowing them to implant a pacemaker or ICD to prevent severe complications.
In this answer
3 sections
Not everyone with myotonic dystrophy type 1 (DM1) will need a pacemaker or an implantable cardioverter defibrillator (ICD), but because DM1 progressively affects the heart’s electrical system, it is a very common intervention [1]. The likelihood of needing a device is not based strictly on your age, but rather on the size of your genetic mutation (CTG repeat expansion) and specific physical changes in how electrical signals travel through your heart muscle [2]. Regular cardiac monitoring is designed to catch these changes early—often before you feel any symptoms—so doctors can intervene with a pacemaker or ICD to prevent life-threatening complications [3]. Because keeping up with strict routine monitoring can be overwhelming when managing the fatigue or brain fog often seen in DM1, it is highly recommended to bring a care partner to cardiology appointments to help track your care plan.
How DM1 Affects the Heart’s “Wiring”
In DM1, the genetic mutation doesn’t just affect your skeletal muscles; it progressively damages the specialized cells in the heart that generate and conduct electrical impulses [2]. This scarring slows down the electrical signals, a condition known as conduction system disease, which is a hallmark of DM1 [4][1].
If the electrical signals slow down too much, they can become completely blocked (a heart block), causing your heart to beat dangerously slowly. Alternatively, the damaged tissue can trigger erratic, dangerously fast heartbeats (ventricular arrhythmias) [5]. Because severe conduction problems can lead to sudden cardiac death, this routine monitoring is one of the most critical parts of your long-term DM1 care [6].
What Your Doctor is Looking For
When you get an annual resting electrocardiogram (ECG) or wear a 24-hour Holter monitor (which simply involves wearing a few sticky patches on your chest connected to a small, wearable device), your cardiology team is looking for specific electrical delays. The two main measurements they track are:
- PR Interval: This measures the time it takes for the electrical signal to travel from the top chambers of your heart (the atria) to the bottom chambers (the ventricles). A normal PR interval is under 200 milliseconds. A prolonged PR interval (greater than 200 ms) is an early sign of a conduction delay [7][6].
- QRS Duration: This measures how long it takes for the electrical signal to spread through the bottom chambers of your heart. A widened QRS complex (greater than 120 ms) indicates that the signal is struggling to get through the ventricular muscle [7][6].
If your ECG or Holter monitor shows these delays, or if you report symptoms like fainting, your doctor will likely recommend an Electrophysiology Study (EPS) [7]. This procedure involves a catheter that is typically threaded through a vein in your groin to measure the heart’s internal electrical activity. You are given medication to help you relax, and many patients are able to go home the same day.
During an EPS, doctors specifically measure the HV interval, which is the time it takes for a signal to pass through the deepest part of the heart’s wiring. An HV interval of 65 to 70 milliseconds or higher tells your doctor that you are at high risk for a major heart block, even if you feel fine [8][9].
Important Safety Note: People with DM1 have a well-documented, high risk of severe complications from anesthesia and sedatives. If you need an EPS or a device implantation, you must explicitly discuss your DM1 diagnosis with your electrophysiologist and anesthesiologist beforehand to ensure they use DM1-specific anesthesia protocols.
Pacemakers vs. ICDs: What’s the Difference?
If your tests show significant electrical delays or risks, your care team may recommend implanting a device [4]. While they look similar and both are implanted just under the skin of your chest, they serve different primary functions. Living with either device involves routine remote monitoring and a straightforward procedure to replace the battery every 5 to 10 years.
Pacemakers
A pacemaker sends steady electrical pulses to keep your heart beating at a normal rate.
- Why it’s used in DM1: Pacemakers are primarily used to treat slow heart rhythms (bradycardia) or high-grade conduction blocks. If the natural electrical signal gets “stuck” due to scarring, the pacemaker steps in to ensure the heart beats on time [4].
- When it’s recommended: Guidelines often suggest a prophylactic (preventative) pacemaker when an EPS shows a dangerously long HV interval, or if your surface ECG shows advanced conduction disease [8][10].
Implantable Cardioverter Defibrillators (ICDs)
An ICD can act as a pacemaker, but it has a crucial extra function: it continually monitors for dangerously fast rhythms and can deliver a stronger electrical shock to reset a chaotic heartbeat.
- Why it’s used in DM1: While pacemakers prevent the heart from beating too slowly, ICDs are used to prevent fatal arrhythmias and severe cardiac events caused by dangerous, fast ventricular rhythms [4].
- When it’s recommended: Your doctor might recommend an ICD instead of a standard pacemaker if your heart muscle is weakened (a condition known as left ventricular dysfunction) or if you have a documented history of severe, fast arrhythmias [11][12]. Doctors measure this using your Ejection Fraction, which represents the percentage of blood your heart pumps out with each squeeze. In DM1 guidelines, an Ejection Fraction of 50% or less is often considered a threshold that increases your overall risk and might justify an ICD, depending on your broader clinical profile [4].
Doctors use clinical tools—such as the Wahbi risk score or Groh criteria, which factor in your age, specific ECG measurements, and any abnormal rhythms—to decide which device offers the best protection for your specific situation [6][13].
Common questions in this guide
Why do people with myotonic dystrophy often need pacemakers?
What is the difference between a pacemaker and an ICD?
How will my doctor know when I need a pacemaker or ICD?
Are there anesthesia risks if I need a pacemaker implanted for DM1?
Questions for Your Doctor
5 questions
- •What were my specific PR interval and QRS duration numbers on my most recent ECG, and how do they compare to my previous tests?
- •Based on my current ECG and Holter monitor results, am I at a point where an Electrophysiology Study (EPS) is recommended?
- •What is my current Ejection Fraction, and does it suggest I might eventually need an ICD rather than a standard pacemaker?
- •If I ever need a procedure for an EPS or device implantation, how do you coordinate with the anesthesiology team to ensure my DM1-specific anesthesia risks are managed safely?
- •Given my symptoms and DM1 diagnosis, should I be using a longer-term loop monitor instead of just an annual 24-hour Holter to catch any abnormal rhythms?
Questions for You
3 questions
- •Have I experienced any unexplained dizzy spells, heart palpitations, or fainting episodes that I haven't mentioned to my cardiologist?
- •Do I have a care partner who can attend my cardiology appointments to help me track my specific ECG numbers and ask questions?
- •Am I feeling overwhelmed by my strict cardiac monitoring schedule, and if so, how can I set up automated reminders to ensure I don't miss these critical appointments?
Related questions
References
References (13)
- 1
Cardiac Involvement and Arrhythmias Associated with Myotonic Dystrophy.
McBride D, Deshmukh A, Shore S, et al.
Reviews in cardiovascular medicine 2022; (23(4)) doi:10.31083/j.rcm2304126.
PMID: 36177340 - 2
Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
Chong-Nguyen C, Wahbi K, Algalarrondo V, et al.
Circulation. Cardiovascular genetics 2017; (10(3)) doi:10.1161/CIRCGENETICS.116.001526.
PMID: 28611030 - 3
Natural history of cardiac involvement in myotonic dystrophy type 1 - Emphasis on the need for lifelong follow-up.
Petri H, Mohammad BJY, Kristensen AT, et al.
International journal of cardiology 2024; (406()):132070 doi:10.1016/j.ijcard.2024.132070.
PMID: 38643802 - 4
[Myotonic dystrophy type 1 - a rare cause of bradycardia in the young].
Kataja Knight A, Tidehag L, Mattsson G, Magnusson P
Lakartidningen 2020; (117()).
PMID: 31961442 - 5
Cardiac Pathology in Myotonic Dystrophy Type 1.
Mahadevan MS, Yadava RS, Mandal M
International journal of molecular sciences 2021; (22(21)) doi:10.3390/ijms222111874.
PMID: 34769305 - 6
An overview of heart rhythm disorders and management in myotonic dystrophy type 1.
Gossios TD, Providencia R, Creta A, et al.
Heart rhythm 2022; (19(3)):497-504 doi:10.1016/j.hrthm.2021.11.028.
PMID: 34843968 - 7
Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1.
Joosten IBT, van Lohuizen R, den Uijl DW, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2021; (23(2)):298-304 doi:10.1093/europace/euaa256.
PMID: 33150426 - 8
Electrocardiogram vs Electrophysiological Study and Major Conduction Delays in Myotonic Dystrophy Type 1.
Clementy N, Labombarda F, Grolleau F, et al.
JAMA cardiology 2025; (10(11)):1121-1129 doi:10.1001/jamacardio.2025.3055.
PMID: 40991257 - 9
Myotonic Dystrophy.
Perez PG
Continuum (Minneapolis, Minn.) 2025; (31(5)):1437-1461 doi:10.1212/cont.0000000000001621.
PMID: 41037177 - 10
Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
Cardona A, Arnold WD, Kissel JT, et al.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2019; (21(1)):26 doi:10.1186/s12968-019-0535-6.
PMID: 31046780 - 11
The Controversial Epidemiology of Left Ventricular Dysfunction in Patients With Myotonic Dystrophy Type 1.
Russo V, Papa AA, Nigro G
JAMA cardiology 2017; (2(9)):1044 doi:10.1001/jamacardio.2017.0927.
PMID: 28492909 - 12
Ventricular tachycardia in patients with type 1 myotonic dystrophy: a case series.
Nikhanj A, Sivakumaran S, Miskew-Nichols B, et al.
European heart journal. Case reports 2019; (3(2)) doi:10.1093/ehjcr/ytz095.
PMID: 31449640 - 13
Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1.
Itoh H, Hisamatsu T, Tamura T, et al.
Journal of the American Heart Association 2020; (9(17)):e015709 doi:10.1161/JAHA.119.015709.
PMID: 32812471
This page explains myotonic dystrophy heart complications and device treatments for educational purposes. Always consult your cardiologist or electrophysiologist regarding your specific cardiac monitoring and treatment needs.
Get notified when new evidence is published on Steinert myotonic dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.